92% OF COMMERCIAL PATIENTS NATIONALLY ARE COVERED FOR DUPIXENTa

aMMIT and Dedham Group Analysis, March 2020.

Coverage and support for eligible patients

Help ensure your eligible patients start and stay on DUPIXENT

DUPIXENT MyWay® is a support program that can help optimize access to DUPIXENT and provides:

To enroll in DUPIXENT MyWay, your patients can call 1‑844‑DUPIXEN(T).


DUPIXENT MyWay Enrollment Forms:

Our team will provide assistance navigating the insurance process

Benefits Investigation
Verifies your patient’s specific health plan coverage for DUPIXENT, as well as copay information


Prior Authorization (PA)b

  • If a PA is required, your DUPIXENT MyWay Coordinator can help you navigate the PA process
  • Your DUPIXENT MyWay Coordinator will follow up with the payer regarding the status of the PA on an ongoing basis

Appeals Supportc

  • If coverage is denied, your DUPIXENT MyWay Coordinator will help you and your patients understand the appeals process
  • DUPIXENT MyWay can also provide educational tools, such as a sample letter of medical necessity and sample letters of appeal, to help with the process if you are not already familiar with the process
  • Our experienced team of appeals nurses is available to help understand the appeals process
  • Download a complete guide and sample letters regarding coverage for DUPIXENT:

CoverMyMeds SpecialtyPlus Support is available for DUPIXENT!

CoverMyMeds provides additional prior authorization process related support for DUPIXENT.

Live support is available at 866-452-5017/covermymeds.com

DUPIXENT MyWay resources can help your patients access DUPIXENT

Copay Carde
Eligible patients covered by commercial health insurance may pay as little as $0 for DUPIXENT (maximum of $13,000 per patient per calendar year)


Patient Assistance Program
If patients meet these eligibility requirements, DUPIXENT may be provided at no cost, subject to program terms and conditionsf:

  • Must be a resident of the 50 United States, the District of Columbia, or Puerto Rico
  • Must be treated by an HCP in the 50 United States, the District of Columbia, or Puerto Rico
  • Must use DUPIXENT for an indication approved by the US Food and Drug Administration
  • Must not be an inpatient
  • Must meet financial criteria. If patient is aged <18 years, a parent or legal guardian must meet financial criteriag
  • b DUPIXENT MyWay can provide certain limited support.
  • c Approval is not guaranteed. Appealing the health plan's denial does not always result in approval of DUPIXENT.
  • d Eligible patients subject to program restrictions.
  • e THIS IS NOT INSURANCE. Not valid for prescriptions paid, in whole or in part, by Medicaid, Medicare, VA, DoD, TRICARE, or other federal or state programs.
  • f Eligible commercial patients receive 30-day supply shipments for 12 months at no cost unless eligibility status changes. Patients may reapply after 12 months if they still meet the criteria. Medicare patients with or without the Part D (pharmacy) benefit may qualify and may receive 30-day supply shipments for up to 1 calendar year. Assistance period for Medicaid patients varies based on eligibility criteria. Restrictions may apply.
  • g Patients are considered for eligibility based on individual circumstances.

DUPIXENT MyWay takes a patient-centric approach to educating and empowering patients to use and stay on DUPIXENT

DUPIXENT MyWay Nurse Educators
Every enrolled patient is assigned a phone-based DUPIXENT MyWay Nurse Educator

  • Within 1 business day after receiving a completed and signed enrollment form, the Nurse Educator will contact your patient and introduce the program
  • The Nurse Educator will provide benefit information as soon as the benefits investigation is complete and help the patient through the process of getting started on DUPIXENT

Disease and Treatment Education

  • Ongoing follow-ups and education are provided by the Nurse Educator to help patients stay on track with DUPIXENT
  • Supplemental injection training and planning—in person or over the phone—help patients get comfortable injecting themselves and planning their treatment calendar

DUPIXENT MyWay offers support at 1-844-DUPIXEN(T) (1-844-387-4936)

DUPIXENT® and DUPIXENT MyWay® are registered trademarks of Sanofi Biotechnology.


Questions about the insurance process?

Our team will provide guidance and assistance during the insurance approval process. If your patients need further support, DUPIXENT MyWay Nursing Support is available as a dedicated single point of contact.

1

Prescribe DUPIXENT.

2

Submit the
DUPIXENT MyWay enrollment form.


DUPIXENT MyWay Enrollment Forms:

3

DUPIXENT MyWay completes a benefits investigation and determines whether there are any requirements for prior authorization for DUPIXENT.

Submit a Letter of Medical Necessity and include all required documentation (eg, a copy of your chart notes with details of diagnosis, disease severity, and treatment history).

4

Receive a status update from your DUPIXENT MyWay coordinator.


Approval
DUPIXENT MyWay
representative arranges shipment via specialty pharmacy (in network) or patient arranges shipment with specialty pharmacy (out of network).

Appeals

If a PA is denied, you can fill out an appeal form, write an appeal letter, and add supporting documentation.


Sample Lettersh:

  • h The letters provide examples of information that may be provided when responding to an insurance company; they are not intended to substitute for or to influence the independent medical judgment of physicians.